Type D Personality and Chronic Kidney Disease as Predictors of Pro- and Anti- Inflammatory Cytokine Levels in Heart Failure Interleukin-6 (IL-6), tumor.

Slides:



Advertisements
Similar presentations
Introduction and Aim Research indicates that socioeconomic status (SES) is an important predictor of mortality and morbidity. Low SES increases susceptibility.
Advertisements

Mayrene Hernandez, DO Advanced ProMed Inc. Billing and Management Solutions Board Certified in Family Medicine Clinical Assistant Professor for NSU.
The Importance of Beta-Blockers in Patients with Heart Failure: A Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT) Analysis.
CKD In Primary Care Dr Mohammed Javid.
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Johan Denollet, PhD the heart failure patient ? Why is a dedicated cardiologist not sufficient for The Netherlands.
Outcome of Patients with Advanced Heart Failure who Receive Device- Based Therapy for Primary Prevention of Sudden Cardiac Death, G. Amit, N. Samniah,
The long-term outcome after acute renal failure Presented by Ri 顏玎安.
CREATININE AND CYSTATIN-C BASED GFRs VS 51 Cr-EDTA GFR IN PATIENTS WITH DECOMPENSATED CIRRHOSIS 1 4th Department of Internal Medicine, Hippokration General.
Sex Differences in Implantable Cardioverter Defibrillator (ICD) Implantation indications and outcomes Guy Amit, MD; Mahmoud Suleiman, MD; Mark Kazatsker,
Change in prevalence of Chronic Kidney Disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.
Estimated GFR Based on Creatinine and Cystatin C
Background: Heart failure (HF) is an incurable life-long disease with poor prognosis. Symptoms such as dyspnea cause limitation in patients’ daily life.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
CGS BILLING SERVICE
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Clinical Appraisal of an Article on Prognosis. The Clinical Question What is the risk of mortality among patients with hyperuricemia who received allupurinol?
Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders Robert S. Katz 1, Frederick Wolfe 2. 1 Rush University Med Center,
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
Comparison of Blood Pressure Lowering with Hydrochlorothiazide and Chlorthalidone Kurt A. Wargo, Pharm.D., BCPS, Thomas M. English, Ph.D., Anna J. Aaron,
Purpose and Hypothesis Results Implications Discussion Acknowledgment Background State/Trait Depression and Hostility as Predictors of Interleukin-6 Levels.
Clinical Characteristic of Patients with Uncontrolled, Potentially Under-treated and Apparent Treatment Resistant Hypertension: NHANES 1988  Brent.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Association of C-Reactive Protein and Acute Myocardial Infarction in HIV-Infected Patients Virginia A. Triant, MD, MPH, James B. Meigs, MD, MPH, and Steven.
Bicarbonate-Based Solutions in the Management of Acute Kidney Injury Vania Cecilia Prudencio-Ribera, MD 1 ; Universidad Mayor de San Simón, School of Medicine,
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Predicting Progression in Diabetic Nephropathy: New Biomarker: sTNFR1* Circulating soluble Tumor Necrosis Factor Receptor 1.
Which Beta-Blocker is Best for Patients with Heart Failure? Summary and Comment by Joel M. Gore, MD Published in Journal Watch Cardiology December 17,
Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) Trial PEECH Trial Presented at The American College of Cardiology Scientific Sessions.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
CoRPS Center of Research on Psychology in Somatic diseases Tilburg University The Netherlands Predictors of posttraumatic stress (PTSD) 18 months post.
CoRPS Center of Research on Psychology in Somatic diseases Type D personality & haemoglobin in CHF Nina Kupper PhD Aline Pelle PhD Balázs M. Szabó MD PhD.
CoRPS Disclosures None. CoRPS Center of Research on Psychology in Somatic diseases Impact of psychological profile in heart failure patients Susanne S.
CoRPS Center of Research on Psychology in Somatic diseases Inflammation, Mediation and Type D personality Multiple inflammatory biomarkers as mediators.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response.
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
Correlates of Patient Acceptance of the Cardioverter-Defibrillator: Cross-validation of the Florida Patient Acceptance Survey in Danish Patients Correlates.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
CoRPS Center of Research on Psychology in Somatic diseases Depression is associated with a 2-fold independent risk of mortality in implantable cardioverter.
Journal of the American College of Cardiology Vol. 52, No. 9, 2008 R1. 이 홍 주.
1 Predicting Dementia From Vascular Conditions Among Tennessee Medicare Elderly Baqar A. Husaini, PhD Professor & Director, Center for Health Research.
PJ Devereaux, MD, PhD McMaster University
Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
John Weeks1, MD Candidate 2017, Justin Hickman1, MD Candidate 2017
Copyright © 2006 American Medical Association. All rights reserved.
Chapter 1: CKD in the General Population
Volume 80, Issue 1, Pages (July 2011)
The Association of Co-Morbid Symptoms of Depression and Anxiety With All-Cause Mortality in Patients With Heart Failure Abdullah S. Alhurani, PhDc, MSN,
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Regadenoson Use in Chronic Kidney Disease and End-Stage.
by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E
Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome Johanna E. Emmens, BSc, Jozine M. ter Maaten, MD, Yuya Matsue,
CLINICAL DILEMMAS IN HEART FAILURE:
Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,
The percentage of subjects with de novo development of renal function impairment (GFR
Kuwabara et al. Am J Nephrol 2017;45:   (DOI: / )
Volume 80, Issue 1, Pages (July 2011)
Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From.
Thinking Beyond New Clinical Guidelines: Update in Hypertension
Chapter 1: CKD in the General Population
Obesity and Heart Failure: Focus on the Obesity Paradox
Balance of proinflammatory and antiinflammatory cytokines at thoracic cancer operation  Darryl M Atwell, MD, Katherine P Grichnik, MD, Mark F Newman, MD,
Presentation transcript:

Type D Personality and Chronic Kidney Disease as Predictors of Pro- and Anti- Inflammatory Cytokine Levels in Heart Failure Interleukin-6 (IL-6), tumor necrosis factor- (TNF-) and soluble TNF- receptors 1 (sTNFR1) and 2 (sTNFR2) are powerful predictors of mortality in chronic heart failure (CHF). However, little is known about (i) the origins of pro- inflammatory cytokine production and (ii) the determinants of substantial interpatient variability in immune activation. We prospectively examined Type D personality (tendency to experience and inhibit emotional distress) and chronic kidney disease (CKD) as predictors of cytokine production in patients with CHF. BACKGROUNDBACKGROUND Dr. Nina Kupper, CONTACT INFORMATION Type D personality At 1yr FU, Type D patients had significantly elevated levels of sTNFR1 (p =0.009) and sTNFR2 (p =0.001), and decreased levels of IL-10 (p =0.006) as compared to patients without Type D or CKD. CKD Patients with CKD also had elevated levels of sTNFR1 and sTNFR2 (p <0.0001), but their IL-10 level was not decreased. Predictive qualities In multivariable analyses, Type D personality and CKD independently predicted increased sTNFR1/IL-10 and sTNFR2/IL-10 ratios (all p s≤0.007); Type D also predicted an increased IL-6/IL-10 ratio (p =0.013). Covariates spironolactone and older age were also associated with elevated PIC/AIC ratios. Adjusting for these variables, the odds to have elevated ratios (highest 20%) was still increased in Type D patients and in patients with CKD (see Figures 1a-c & table 1). Type D personality At 1yr FU, Type D patients had significantly elevated levels of sTNFR1 (p =0.009) and sTNFR2 (p =0.001), and decreased levels of IL-10 (p =0.006) as compared to patients without Type D or CKD. CKD Patients with CKD also had elevated levels of sTNFR1 and sTNFR2 (p <0.0001), but their IL-10 level was not decreased. Predictive qualities In multivariable analyses, Type D personality and CKD independently predicted increased sTNFR1/IL-10 and sTNFR2/IL-10 ratios (all p s≤0.007); Type D also predicted an increased IL-6/IL-10 ratio (p =0.013). Covariates spironolactone and older age were also associated with elevated PIC/AIC ratios. Adjusting for these variables, the odds to have elevated ratios (highest 20%) was still increased in Type D patients and in patients with CKD (see Figures 1a-c & table 1). RESULTSRESULTS N= 125 CHF patients (<80 yrs, LVEF ≤40%, pharmacologically stable) Psychological assessment: Type D personality (DS14) and demographics were assessed at baseline Medical: Chronic kidney disease (CKD) was diagnosed according to the K/DOQI guidelines, by calculating the globular filtration rate (GFR) using the MDRD formula. CKD was defined as either kidney damage or having a decreased kidney function, as assessed by a GFR of <60 ml/min per 1.73m2 at baseline. Serum assessments: At 1 yr FU, pro-inflammatory (PIC) factors IL-6, TNF-a, sTNFR1, sTNFR2, and anti-inflammatory (AIC) factors IL-10 and IL-1ra were assessed. Medical records: Clinical variables (incl. LVEF, NYHA class, etiology, co morbid diseases), biomedical risk factors and medication use. N= 125 CHF patients (<80 yrs, LVEF ≤40%, pharmacologically stable) Psychological assessment: Type D personality (DS14) and demographics were assessed at baseline Medical: Chronic kidney disease (CKD) was diagnosed according to the K/DOQI guidelines, by calculating the globular filtration rate (GFR) using the MDRD formula. CKD was defined as either kidney damage or having a decreased kidney function, as assessed by a GFR of <60 ml/min per 1.73m2 at baseline. Serum assessments: At 1 yr FU, pro-inflammatory (PIC) factors IL-6, TNF-a, sTNFR1, sTNFR2, and anti-inflammatory (AIC) factors IL-10 and IL-1ra were assessed. Medical records: Clinical variables (incl. LVEF, NYHA class, etiology, co morbid diseases), biomedical risk factors and medication use. METHODSMETHODS Nina Kupper PhD, Angélique A. Schiffer Msc, Martijn Kwaijtaal PhD, Herbert Hooijkaas PhD, Eric H. Hendriks RN, Jos W. Widdershoven MD PhD, Johan Denollet PhD Co RPS, Medical Psychology, Tilburg University & TweeSteden Hospital, Tilburg, The Netherlands Both Type D personality and CKD independently predict unfavorable cytokine profiles in CHF patients. Such alterations in immune processes may be one mechanism explaining the adverse relationship between these risk factors and prognosis in heart failure. Whether these Type D and CKD related alterations in immune balance actually explain adverse prognosis and mortality in CHF patients is subject for further study. Limitations As only 25% of the sample was female, this might have precluded finding sex differences. Only a limited amount of patients had both CKD and Type D. Potential additive effects would be able to specify those high at risk even further Both Type D personality and CKD independently predict unfavorable cytokine profiles in CHF patients. Such alterations in immune processes may be one mechanism explaining the adverse relationship between these risk factors and prognosis in heart failure. Whether these Type D and CKD related alterations in immune balance actually explain adverse prognosis and mortality in CHF patients is subject for further study. Limitations As only 25% of the sample was female, this might have precluded finding sex differences. Only a limited amount of patients had both CKD and Type D. Potential additive effects would be able to specify those high at risk even further CONCLUSIONSCONCLUSIONS Elevated RatioType D PersonalityOdds Ratio [95% CI]p-value sTNFR1/IL-10Type D3.92 [ ].034 Age 70 yrs 0.65 [ ].54 Spironolactone5.68 [ ].013 Beta blocker0.37 [ ].13 sTNFR2/IL-10Type D18.88 [ ].001 Age 70 yrs 7.94 [ ].006 Spironolactone2.77 [ ].23 Beta blocker0.19 [ ].036 IL-6/IL-10Type D3.12 [ ].044 Age 70 y 2.22 [ ].16 Spironolactone1.44 [ ].59 Beta blocker1.13 [ ].84 Chronic Kidney Disease sTNFR1/IL-10CKD4.23 [ ].009 Age 70 yrs 0.70 [ ].49 Spironolactone2.24 [ ].14 Beta blocker0.48 [ ].15 sTNFR2/IL-10CKD7.75 [ ].003 Age 70 yrs 4.04 [ ].01 Spironolactone0.94 [ ].93 Beta blocker0.73 [ ].60 Figure 1a-c. Percentage of patients with elevated ratios of PIC vs. AIC in Type D personality and CKD patients compared with a non Type D, non CKD reference group Table 1. Type D personality and chronic kidney disease as predictors of a pro vs. anti inflammatory cytokine imbalance Reference CKD Type D Reference CKD Type D Reference CKD Type D.16.05